Objective: To compare the efficacy and safety of combination of Aidi injection and chemotherapy and chemotherapy alone in treatment of breast cancer.
Methods: The related control and randomized studies till August 1, 2020, were retrieved in the database including PubMed, Embase, Cochrane Library, CNKI, CBM, Wang-Fang, and VIP. Primary outcomes were response rate (RR) and performance status (KPS) improvement rate; secondary outcomes were rate of adverse drug reactions (ADR) including myelosuppression, digestive tract reaction, liver dysfunction, and cardiac toxicity. Review Manager 5.3 was used in the present analysis.
Results: In total, 20 studies (18 articles) were included in the present analysis. RR (OR 1.76 (1.32, 2.35); =0.0001) and KPS improvement rate (OR: 2.68 (1.34, 6.46); =0.007) in Aidi injection plus chemotherapy group were significantly higher than those of chemotherapy alone group. Addition of Aidi injection significantly reduced the rate of myelosuppression, digestive tract reaction, leukocyte decrease, II-IV cardiac function abnormality, atrial dysrhythmia, ventricular arrhythmia, ST segment T wave inversion, and abnormal ECG (all < 0.05).
Conclusion: Aidi injection could increase the efficacy of chemotherapy, could reduce myelosuppression, digestive tract reaction, and cardiac toxicity induced by chemotherapy, and did not lead to additional toxicity and side effect. Therefore, it is an anticancer drug with good efficacy and low toxicity, worth further popularization.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7810520 | PMC |
| http://dx.doi.org/10.1155/2021/8832913 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Aidi injection inhibits the migration and invasion of gefitinib-resistant lung adenocarcinoma cells by regulating the PLAT/FAK/AKT pathway.
Chin Med
January 2025
Department of Clinical Chinese Pharmacy, School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, 102488, China.
Background: With extended gefitinib treatment, the therapeutic effect in some non-small cell lung cancer (NSCLC) patients declined with the development of drug resistance. Aidi injection (ADI) is utilized in various cancers as a traditional Chinese medicine prescription. This study explores the molecular mechanism by which ADI, when combined with gefitinib, attenuates gefitinib resistance in PC9GR NSCLC cells.
View Article and Find Full Text PDFRapid and simple fluorescent detection of chlorogenic acid in Aidi injection using aggregation-induced emission (AIE) nanoclusters.
J Pharm Biomed Anal
February 2025
Institute of Pharmaceutical Analysis, College of Pharmacy/State Key Laboratory of Bioactive Molecules and Druggability Assessment/Guangdong Province Key Laboratory of Pharmacodynamic Constituents of TCM and New Drugs Research of China, Jinan University, Guangzhou 510632, China. Electronic address:
Article Synopsis
- Chlorogenic acid (CGA) is crucial in Aidi injection for its anti-cancer effects, making its accurate detection important for treatment monitoring.
- A new fluorescent detection method using DPA-capped bimetallic gold/copper nanoclusters (DPA-Au/CuNCs) is introduced, which shows rapid response and sensitivity to CGA levels in the injection.
- This method effectively identifies CGA in Aidi injection and plasma with high recovery rates, suggesting its usefulness in pharmaceutical and clinical settings.
Syringin: a naturally occurring compound with medicinal properties.
Front Pharmacol
July 2024
Institute of Radiation Medicine Sciences, Beijing, China.
Syringin, a phenylpropanoid glycoside, is widely distributed in various plants, such as (Rupr. et Maxim.) Harms, (BL) Hara var.
View Article and Find Full Text PDFBibliometric Analysis and Systemic Review of Cantharidin Research Worldwide.
Curr Pharm Biotechnol
July 2024
School of Pharmacy and Key Laboratory of Basic Pharmacology Ministry Education and Joint International Research Laboratory of Ethnomedicine, Ministry of Education, Zunyi Medical University, Zunyi 563000, Guizhou, China.
Background: Cantharidin (CTD), a natural toxic compound from blister beetle Mylabris, has been used for cancer treatment for millenary. CTD and its analogs have become mainstream adjuvant drugs with radiotherapy and chemotherapy in clinical applications. However, the detailed pharmacology mechanism of CTD was not fully elucidated.
View Article and Find Full Text PDFCombination of Brucea javanica oil emulsion and Aidi injection associated with the long‑term survival of a patient with colon cancer and lung metastases post‑chemotherapy: A case report.
Oncol Lett
August 2024
Department of Oncology, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai 200437, P.R. China.
Colorectal cancer (CRC) ranks as the third most frequently diagnosed cancer and the fourth leading cause of cancer-related mortality worldwide. Treatment options for patients with advanced CRC recurrence and metastases remain limited, particularly for those unable to withstand chemotherapy. oil emulsion (BJOE) and Aidi injection (ADI) are two plant-derived products that have antitumor effects.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!